J&J gets FDA authorization for Ottava robot, teeing up competition with Intuitive

Johnson & Johnson received FDA authorization for its Ottava robotic surgery system, directly challenging Intuitive Surgical's market dominance in surgical robotics. Analysts express scepticism about J&J's ability to capture meaningful market share from the entrenched leader.

This Wire brief sits within Fusion42's coverage of Digital Health. Wire is Fusion42's founder-focused intelligence feed: each story is connected to the funds and startups it names — every one with a live profile on Raise or Scout — so founders can follow the capital and the momentum behind the headline rather than just the headline itself. Wire analysis is one of the live surfaces Arthur reasons over.